These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Apr 18, 2013
Agenus Inc. (Nasdaq:AGEN) will release its first quarter 2013 financial results before the market opens on April 24, 2013. Agenus executives will host a conference call at 11:00 a.m. Eastern Time...
Apr 10, 2013Agenus’ Brain Cancer Vaccine Results to be Presented at Plenary Session of the 81st American Association of Neurological Surgeons (AANS) Annual Scientific MeetingFirst Phase 2 Data From Prophage G-100 (HSPPC-96) Newly Diagnosed Glioma Program
Agenus Inc. (NASDAQ: AGEN) reported today that Orin Bloch, MD, Clinical Instructor, Department of Neurological Surgery, University of California San Francisco (UCSF), will present an abstract that...
Mar 14, 2013
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the 25th Annual ROTH Conference, which...
Feb 28, 2013Agenus to Host Conference Call Beginning at 11 a.m. ET Today
Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business...
Feb 27, 2013HerpV is clinically the most advanced therapeutic vaccine for the treatment of genital herpes
Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced it has completed patient screening in its Phase 2 randomized, double-blind,...